Join us for an exclusive MedTalk with Dr. Philippe Legenne, Chief Medical Officer at Molecular Partners, a Swiss biotech company pioneering novel therapies with its DARPin® platform. Dr. Legenne holds a doctorate in medicine from the university of Lille, after getting an MBA and covering different positions at Novartis, GSK and J&J, he worked as Executive Medical Director at Amgen. Since 2020 he is with Molecular Partners, where he currently cover the role of Chief Medical Officer. Don’t miss this opportunity to hear from a leading expert at the intersection of science, medicine, and innovation, and to gain valuable perspectives on the future of biotech and patient care!
